Negative regulation of the bovine papillomavirus E5, E6, and E7 oncogenes by the viral E1 and E2 genes
- PMID: 7983735
- PMCID: PMC188587
- DOI: 10.1128/JVI.69.1.395-402.1995
Negative regulation of the bovine papillomavirus E5, E6, and E7 oncogenes by the viral E1 and E2 genes
Abstract
Papillomaviruses induce benign squamous epithelial lesions that infrequently are associated with uncontrolled growth or malignant conversion. The virus-encoded oncogenes are clearly under negative regulation since papillomaviruses can latently infect cells and since different levels of viral oncogene expression are seen within the layers of differentiating infected epitheliomas. We used bovine papillomavirus type 1 (BPV-1) to investigate the mechanisms involved in the negative regulation of transformation. We found that the following two distinct and interacting mechanisms negatively regulate BPV-1 transformation effected by virally encoded trans-acting factors: (i) E2 repressors suppress transformation by the E6 and E7 oncogenes, and (ii) E1 and the E2 transactivator suppress transformation by the E6, E7, and E5 oncogenes. These systems interact in that the E2 repressors function to relieve the transformation suppression effected by the E1 and E2 transactivator genes. A BPV-1 mutant that lacked E2 repressors and E1 had greatly augmented transformation capacity. Analysis of this mutant revealed that the enhanced transformation was due to expression of the E6 and E7 genes in the absence of E5, revealing a previously unappreciated potency and synergy for the BPV-1 E6 and E7 oncogenes.
Similar articles
-
Role of transcriptional repressors in transformation by bovine papillomavirus type 1.J Virol. 1994 Oct;68(10):6787-93. doi: 10.1128/JVI.68.10.6787-6793.1994. J Virol. 1994. PMID: 8084016 Free PMC article.
-
Identification and genetic definition of a bovine papillomavirus type 1 E7 protein and absence of a low-copy-number phenotype exhibited by E5, E6, or E7 viral mutants.J Virol. 1992 Aug;66(8):4957-65. doi: 10.1128/JVI.66.8.4957-4965.1992. J Virol. 1992. PMID: 1321280 Free PMC article.
-
Suppression of cellular proliferation by the papillomavirus E2 protein.J Virol. 1995 Dec;69(12):7791-9. doi: 10.1128/JVI.69.12.7791-7799.1995. J Virol. 1995. PMID: 7494290 Free PMC article.
-
[Genetic regulation of human genital papillomaviruses].Salud Publica Mex. 1995 May-Jun;37(3):241-7. Salud Publica Mex. 1995. PMID: 7676352 Review. Spanish.
-
The bovine papillomavirus replicon.Ciba Found Symp. 1986;120:53-67. doi: 10.1002/9780470513309.ch5. Ciba Found Symp. 1986. PMID: 3013526 Review.
Cited by
-
Molecular Mechanisms of MmuPV1 E6 and E7 and Implications for Human Disease.Viruses. 2022 Sep 28;14(10):2138. doi: 10.3390/v14102138. Viruses. 2022. PMID: 36298698 Free PMC article. Review.
-
Identification of a second transforming function in bovine papillomavirus type 1 E6 and the role of E6 interactions with paxillin, E6BP, and E6AP.J Virol. 2000 Jan;74(2):812-6. doi: 10.1128/jvi.74.2.812-816.2000. J Virol. 2000. PMID: 10623743 Free PMC article.
-
Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6.J Virol. 1997 Jun;71(6):4866-70. doi: 10.1128/JVI.71.6.4866-4870.1997. J Virol. 1997. PMID: 9151888 Free PMC article.
-
Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells.J Virol. 2005 Dec;79(23):14956-61. doi: 10.1128/JVI.79.23.14956-14961.2005. J Virol. 2005. PMID: 16282494 Free PMC article.
-
Human TATA binding protein inhibits human papillomavirus type 11 DNA replication by antagonizing E1-E2 protein complex formation on the viral origin of replication.J Virol. 2002 May;76(10):5014-23. doi: 10.1128/jvi.76.10.5014-5023.2002. J Virol. 2002. PMID: 11967317 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources